GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Fixed Maturity Investment

ImmuPharma (LSE:IMM) Fixed Maturity Investment


View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Fixed Maturity Investment?

Fixed Maturity Investment only applies to insurance companies.


ImmuPharma Business Description

Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease.